Baculovirus-mediated expression of cytochrome P4502C8 and human NADPH-cytochrome p450 reductase: Optimization of protein expression

Xenobiotica

Volumn 28, Issue 2, 1998, Pages 137-152

  Ong, C E ^a   Miners, J O ^a   Birkett, D J ^a   Bhasker, C R ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450; OXYGENASE; POLYHEDRIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; TOLBUTAMIDE;

ANIMAL CELL; ARTICLE; BACULOVIRUS; CELL LYSATE; CLONE; ENZYME ACTIVITY; EXPRESSION VECTOR; GENE; GENE EXPRESSION SYSTEM; HUMAN; LEPIDOPTERA; MICROSOME; NONHUMAN; PLASMID; PROMOTER REGION; PROTEIN EXPRESSION;

ANIMALS; BACULOVIRIDAE; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION; HEMIN; HUMANS; MICROSOMES; MIXED FUNCTION OXYGENASES; NADPH-FERRIHEMOPROTEIN REDUCTASE; PLASMIDS; RECOMBINANT PROTEINS; SPODOPTERA; TRANSFECTION;

ANIMALIA; LEPIDOPTERA; SPODOPTERA FRUGIPERDA; UNIDENTIFIED BACULOVIRUS;

EID: 0031888170     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982598239641     Document Type: Article

References (45)

1. ASSEFFA, A., SMITH, S. J., NAGATA, K., GILLETTE, J., GELBOIN, H. V. and GONZALEZ, F. J., 1989, Novel exogenous heme-dependent expression of mallalian cytochrome P450 using baculovirus. Archives of Biochemistry and Biophysics, 274, 481-490.
2. BARNES, H. J., JENKINS, C. M. and WATERMAN, M. R., 1994, Baculovirus expression of bovine cytochrome P450c17 in Sf9 cells and comparison with expression in yeast, mammalian cells and E. coli. Archives of Biochemistry and Biophysics, 315, 489-494.
3. BIAGINI, C. and CELIER, C., 1996, cDNA-directed expression of two allelic variants of cytochrome P450 2C11 using COS1 and SF21 insect cells. Archives of Biochemistry and Biophysics, 326, 298-305.
4. BUTERS, J. T. M., KORZEKWA, K. R., KUNZE, K. L., OMATA, Y., HARDWICK, J. P. and GONZALEZ, F. J., 1994, cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. Drug Metabolism and Disposition, 22, 688-692.
5. BUTERS, J. T. M., SHOU, M., HARDWICK, J. P., KORZEKWA, K. R. and GONZALEZ, F. J., 1995, cDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Drug Metabolism and Disposition, 23, 696-701.
6. CHRISTOPHERSON, P. A., MANKOWSKI, D. A., TWEEDIE, D. J. and LAWTON, M. P., 1995, Expression of human cytochromes P450 in insect cells. Proceedings of International Society for the Study of Xenobiotics, 8, 358.
7. CLARK, B. J. and WATERMAN, M. R., 1991, The hydrophobic amino-terminal sequence of bovine 17∞-hydroxylase is required for the expression of a functional hemoprotein in COS 1 cells. Journal of Biological Chemistry, 266, 5898-5904.
8. DAIKH, B. E., LASKER, J. M., RAUCY, J. L. and KOOP, D. R., 1994, Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. Journal of Pharmacology and Experimental Therapeutics, 271, 1427-1433.
9. DOECKE, C. J., SANSOM, L. N. and MCMANUS, M. E., 1990, Phenytoin 4-hydroxylation by rabbit liver P450IIC3 and identification of orthologs in human liver microsomes. Biochemical and Biophysical Research Communications, 166, 860-866.
10. GOLDSTEIN, J. A. and DE MORAIS, S. M. F., 1994, Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics, 4, 285-299.
11. KERR, B. M., THUMMEL, K. E., WURDEN, C. J., KLEIN, S. M., KROETZ, D. L., GONZALEZ, F. J. and LEVY, R. H., 1994, Human liver carbamazepine metabolism: role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochemical Pharmacology, 47, 1969-1979.
12. KIMURA, S., PASTEWKA, J., GELBOIN, H. V. and GONZALEZ, F. J., 1987, cDNA and amino acid sequences of two members of the human IIC gene subfamily. Nucleic Acids Research, 15, 10053-10054.
13. LÄHDE, M., RAUNIO, H., PELKONEN, O., KARP, M. and OKER-BLOM, C., 1993, Expression of human placental cytochrome P450 aromatase (CYP19) cDNA in insect cells using a luciferase based baculovirus vector. Biochemical and Biophysical Research Communications, 197, 1511-1517.
14. LEE, C. A., KADWELL, S. H., KOST, T. A. and SERABJIT-SINGH, C. J., 1995, CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4. Archives of Biochemistry and Biophysics, 319, 157-167.
15. LEO, M. A., LASKER, J. M., RAUCY, J. L., LIM, C.-I, BLACK, M. and LIEBER, C. S., 1989, Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Archives of Biochemistry and Biophysics, 269, 305-312.
16. LOWRY, O. H., ROSEBROUGH, H. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
17. MCMANUS, M. E., STUPANS, I., BURGESS, W., KOENIG, J. A., HALL, DELAM and BIRKETT, D. J., 1987, Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Drug Metabolism and Disposition, 15, 256-261.
18. MINERS, J. O., SMITH, K. J., ROBSON, R. A., MCMANUS, M. E., VERONESE, M. E. and BIRKETT, D. J., 1988, Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations. Biochemical Pharmacology, 37, 1137-1144.
19. NELSON, D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN, J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH, G., COON, M. J., ESTABROOK, R. W., GUNSALUS, I. C. and NEBERT, D. W., 1996, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1-42.
20. O'REILLY, D. R., MILLER, L. K. and LUCKOW, A. A., 1994, Baculovirus Expression Vectors : A Laboratory Manual (New York: W. H. Freeman).
21. OHTA, D., MATSU-URA, Y. and SATO, R., 1991, Expression and characterization of a rabbit liver cytochrome P450 belonging to P450IIB subfamily with the aid of the baculovirus expression vector system. Biochemical and Biophysical Research Communications, 175, 394-399.
22. OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomal. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2379-2385.
23. PAINE, M. J. I., GILHAM, D., ROBERTS, G. C. K. and WOLF, C. R., 1996, Functional high level expression of cytochrome P450 CYP2D6 using baculoviral expression systems. Archives of Biochemistry and Biophysics, 328, 143-150.
24. 5 on the stoichiometry of P450 2E1-catalyzed reactions. Archives of Biochemistry and Biophysics, 317, 504-513.
25. PEAKMAN, T. C., HARRIS, R. A. and GEWERT, D. R., 1992, Highly efficient generation of recombinant baculoviruses by enzymatically mediated site-specific in vitro recombination. Nucleic Acids Research, 20, 495-500.
26. PENNOCK, G. D., SHOEMAKER, C. and MILLER, L. K., 1984, Strong and regulated expression of Escherichia coli β-galactosidase in insect cells with a baculovirus vector. Molecular and Cellular Biology, 4, 399-406.
27. PORTER, T. D. and COON, M. J., 1991, Cytochrome P-450. Journal of Biological Chemistry, 266, 13469-13472.
28. RAHMAN, A., KORZEKVVA, K. R., GROGAN, J., GONZALEZ, F. J. and HARRIS, J. W., 1994, Selective biotransformation of taxol to 6-hydroxytaxol by human cytochrome P450 2C8. Cancer Research, 54, 5543-5546.
29. RELLING, M. V., AOYAMA, T., GONZALEZ, F. J. and MEYER, U. A., 1990, Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C family. Journal of Pharmacology and Experimental Therapeutics, 252, 442-447.
30. ROHEL, D. Z., COCHRAN, M. A. and FAULKNER, P., 1983, Characterization of 2 abundant messenger RNA species of Autographa californica nuclear polyhedrosis virus present late in infection. Virology, 124, 357-365.
31. ROMKES, M., FALETTO, M. B., BLAISDELL, J. A., RAUCY, J. L. and GOLDSTEIN, J. A., 1991, Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry, 30, 3247-3255.
32. SAKUMA, T., KITAMURA, R., YAKOI, T. and KAMATAKI, T., 1995, Efficient complimentary DNA directed expression of human fetal liver cytochrome P450 (CYP3A7) in insect cells using baculovirus. Biochemistry and Molecular Biology International, 35, 447-455.
33. SIGLE, R. O., TITUS, M. A., HARADA, N. and NELSON, S. D., 1994, Baculovirus mediated high level expression of human placental aromatase (CYP19A1). Biochemical and Biophysical Research Communications, 201, 694-700.
34. SMITH, G. E., SUMMERS, M. D. and FRASER, M. J., 1983, Production of human β-interferon in insect cells infected with a baculovirus expression vector. Molecular and Cellular Biology, 3, 2156-2165.
35. TAKAGI, Y., OGAWA, H., HARADA, N., SHIMADA, H., ISHIMURA, Y. and TAKAGI, Y., 1992, Expression and transport into mitochondria of bovine cytochrome P-450(SCC) in insect cells using the baculovirus expression system. Biochemistry and Biophysical Research Communications, 184, 471-477.
36. TAMURA, S., KORZEKWA, K. R., KIMURA, S., GELBOIN, H. V. and GONZALEZ, F. J., 1992, Baculovirus-mediated expression and functional characterization of human NADPH-P459 oxidoreductase. Archives of Biochemistry and Biophysics, 293, 219-223.
37. TRACY, T. S., ROSENBLUTH, B. W., WRIGHTON, S. A., GONZALEZ, F. J. and KORZEKWA, K. R., 1995, Role of cytochrome P450 2C9 and an allelic variant in the 4′-hydroxylation of (R)- and (5)-flurbiprofen. Biochemical Pharmacology, 49, 1269-1275.
38. VERMILION, J. L. and COON, M. J., 1974, Highly purified detergent-solubilized NADPH-cytochrome P-450 reductase from phenobarbital-induced rat liver microsomes. Biochemical and Biophysical Research Communications, 60, 1315-1322.
39. VERONESE, M. E., DOECKE, C. J., MACKENZIE, P. I., MCMANUS, M. E., MINERS, J. O., REES, D. L. P., GASSER, R., MEYER, U. A. and BIRKETT, D. J., 1993, Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily. Biochemical Journal, 289, 533-538.
40. VERONESE, M. E., MACKENZIE, P. I., DOECKE, C. J., MCMANUS, M. E., MINERS, J. O. and BIRKETT, D. J., 1991, Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9. Biochemical and Biophysical Research Communications, 175, 1112-1118.
41. WEYER, U. and POSSEE, R. D., 1991, A baculovirus dual expression vector derived from the Autographa californica nuclear polyhedrosis virus polyhedrin and p10 promoters: co-expression of two influenza virus genes in insect cells. Journal of General Virology, 72, 2967-2974.
42. WILKINSON, G. R., GUENGERICH, F. P. and BRANCH, R. A., 1989, Genetic polymorphism of S-mephenytoin hydroxylation. Pharmacology and Therapeutics, 43, 53-76.
43. WRIGHTON, S. A., THOMAS, P. E., WILLIS, P., MAINES, S. L., WATKINS, P. B., LEVIN, W. and GUZELIAN, P. S., 1987, Purification of a human liver cytochrome P-450 immunochemically related to several cytochrome P-450 purified from untreated rats. Journal of Clinical Investigation, 80, 1017-1022.
44. YAMANO, S., AOYAMA, T., WESLEY MCBRIDE, O., HARDWICK, J. P., GELBOIN, H. V. and GONZALEZ, F. J., 1989, Human NADPH-P450 oxidoreductase: Complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7. Molecular Pharmacology, 35, 83-88.
45. YUN, C.-H., SHIMADA, T. and GUENGERICH, F. P., 1992, Roles of human liver cytochrome P4502C and 3A enzymes in the 3-hydroxylation of benzo(a)pyrene. Cancer Research, 52, 1868-1874.